ClassID:

20918

A61K38/1709 - page 8 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Recent Application in this class:
#2101
20180117089
2018-05-03

Enhanced reconstitution and autoreconstitution of the hematopoietic compartment

#2102
20180116972
2018-05-03

Lipid based nanocarrier compositions loaded with metal nanoparticles and therapeutic agent

#2103
20180112282
2018-04-26

Methods for inducing cell division of postmitotic cells

#2104
20180110844
2018-04-26

C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency

#2105
20180110843
2018-04-26

C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency

#2106
20180110829
2018-04-26

TAFA4 COMPOUNDS AND USES THEREOF FOR TREATING PAIN

#2107
20180105593
2018-04-19

METHODS AND COMPOSITIONS FOR USING MHC CLASS II INVARIANT CHAIN POLYPEPTIDES AS A RECEPTOR FOR MACROPHAGE MIGRATION INHIBITORY FACTOR

#2108
20180105566
2018-04-19

Myelin oligodendrocyte glycoprotein, myelin basic protein, and proteolipid protein compositions and methods of use

#2109
20180105565
2018-04-19

Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

#2110
20180105563
2018-04-19

Agent for prevention or treatement of corneal disorders

#2111
20180104306
2018-04-19

Method and pharmaceutical composition for use in the treatment of diabetes

#2112
20180099056
2018-04-12

Therapeutic gene cocktail for heart regeneration

#2113
20180099024
2018-04-12

METHODS, COMPOSITIONS, AND KITS INVOLVING ALTERATION OF THE CHAPERONE PROTEIN AXIS IN A SUBJECT

#2114
20180099023
2018-04-12

METHODS OF TREATING IRON OVERLOAD

#2115
20180094238
2018-04-05

Compositions and methods for the induction and tuning of gene expression

#2116
20180092980
2018-04-05

Epicardial-derived paracrine factors for repairing cardiac tissue

#2117
20180092961
2018-04-05

EXTRACELLULAR HISTONES AS BIOMARKERS FOR PROGNOSIS AND MOLECULAR TARGETS FOR THERAPY

#2118
20180092941
2018-04-05

Methods of inducing vascular morphogensis

#2119
20180088130
2018-03-29

Method for detecting anti-vinculin antibodies in a subject with an IBS symptom

#2120
20180088122
2018-03-29

Use of CD36 to identify cancer subjects for treatment

#2121
20180085474
2018-03-29

LIPID NANOPARTICLE COMPOSITIONS

#2122
20180085441
2018-03-29

C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency

#2123
20180085436
2018-03-29

Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and applications thereof

#2124
20180085432
2018-03-29

STING (Stimulator of Interferon Genes), A Regulator of Innate Immune Responses

#2125
20180085420
2018-03-29

Ezetimibe-associated ApoA-I mimetic peptides showing enhanced synergism

#2126
20180085296
2018-03-29

TRPV3 agonists for the treatment of skin conditions

#2127
20180080046
2018-03-22

Viral vectors for the treatment of retinal dystrophy

#2128
20180078683
2018-03-22

Rapamycin 40-O-Cyclic Hydrocarbon Esters, Compositions and Methods

#2129
20180078611
2018-03-22

Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins

#2130
20180078610
2018-03-22

Hot flash-suppressing agent

#2131
20180078609
2018-03-22

METHODS AND COMPOSITIONS FOR TREATING ALZHEIMER'S DISEASE AND OTHER MEMORY-ASSOCIATED DISORDERS AND CONDITIONS

#2132
20180077923
2018-03-22

Alpha connexin C-terminal (ACT) peptides and methods of use thereof

#2133
20180072811
2018-03-15

Anti-CSPG4 reagents and methods of treating cancer

#2134
20180072796
2018-03-15

Mast cell stabilizers for treatment of hypercytokinemia and viral infection

#2135
20180071364
2018-03-15

Transcription factor-based generation of pacemaker cells and methods of using same

#2136
20180071363
2018-03-15

Alpha connexin c-terminal (ACT) peptides and methods of use thereof

#2137
20180071362
2018-03-15

Method for treating cancer by adminstering poly I:C and LAG-3-IgG fusion protein

#2138
20180066279
2018-03-08

RECOMBINANT AAV VECTORS USEFUL FOR REDUCING IMMUNITY AGAINST TRANSGENE PRODUCTS

#2139
20180066252
2018-03-08

p63 inactivation for the treatment of heart failure

#2140
20180066052
2018-03-08

COMPOSITIONS AND METHODS FOR REGULATING SAS1R

#2141
20180066039
2018-03-08

Mast cell stabilizers for treatment of hypercytokinemia and viral infection

#2142
20180064965
2018-03-08

Peptide for promoting hair growth

#2143
20180064785
2018-03-08

Method of ameliorating or preventing the worsening or the progression of symptoms of BPH

#2144
20180064784
2018-03-08

LIQUID NUTRITIONAL FORMULA FOR TYROSINEMIA PATIENTS

#2145
20180057813
2018-03-01

Compositions and methods for nucleic acid transfer

#2146
20180057568
2018-03-01

Removal of serine proteases by treatment with finely divided silicon dioxide

#2147
20180057550
2018-03-01

Methods and compositions for regenerating tissues

#2148
20180055928
2018-03-01

Tumor specific oligosaccharide epitopes and use thereof

#2149
20180055910
2018-03-01

Method of prevention and inhibition of preterm labor

#2150
20180055908
2018-03-01

Prevention and/or treatment of hearing loss or impairment

#2151
20180055907
2018-03-01

COMPOSITIONS COMPRISING SEMAPHORINS FOR THE TREATMENT OF CANCER AND METHODS OF SELECTION THEREOF

#2152
20180051060
2018-02-22

Cell-permeable (iCP)-SOCS3 recombinant protein and uses thereof

#2153
20180050086
2018-02-22

Use of Glycomacropeptide to Improve Women's Health

#2154
20180045740
2018-02-15

METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES

#2155
20180043035
2018-02-15

RP2 and RPGR vectors for treating X-linked retinitis pigmentosa

#2156
20180042992
2018-02-15

TREATMENT OF EYE DISEASE

#2157
20180042951
2018-02-15

Glucocerebroside treatment of liver disorders

#2158
20180037622
2018-02-08

Methods for treating refractory anemia with ringed sideroblasts

#2159
20180036385
2018-02-08

AAV-mediated gene therapy for RPGR X-linked retinal degeneration

#2160
20180036373
2018-02-08

Use of haptoglobin subunit for promoting wound healing

#2161
20180036372
2018-02-08

Treatment agent for cognitive impairment induced by amyloid beta-protein, therapeutic agent for alzheimer's disease, and treatment method and pathological analysis method related to these

#2162
20180036371
2018-02-08

Dermatopontin as a therapeutic for metabolic disorders

#2163
20180036370
2018-02-08

Use of haptoglobin subunit for promoting angiogenesis

#2164
20180028651
2018-02-01

Combination therapy for treatment of coronary artery disease

#2165
20180028605
2018-02-01

PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF CANCER COMPRISING EI24 PROTEIN OR ITS ENCODING GENE

#2166
20180028604
2018-02-01

Semaphorin 3A for treatment and assessment of severity of inflammatory bowel disease

#2167
20180028603
2018-02-01

A PROTEIN BASED ON ZG16 FOR USE AS A MEDICAMENT

#2168
20180028599
2018-02-01

MCJ agonists and uses therefor

#2169
20180028598
2018-02-01

Compostions for Treating Dry Eye Disease

#2170
20180028449
2018-02-01

Technology for the Preparation of Microparticles

#2171
20180028445
2018-02-01

CNS delivery of MRNA and uses thereof

#2172
20180024138
2018-01-25

Frizzled-4 mutation indicator of retinopathy and intrauterine growth restriction

#2173
20180022793
2018-01-25

CHEMOREPULSION OF CELLS

#2174
20180021430
2018-01-25

SELECTIVE TARGETING OF THE CD40L/MAC-1 INTERACTION BY SMALL PEPTIDE INHIBITORS AND ITS USE FOR THE TREATMENT OF INFLAMMATION AND ATHEROGENESIS

#2175
20180021388
2018-01-25

Avian follistatin product

#2176
20180016320
2018-01-18

Methods and compositions for modulating toso activity

#2177
20180016312
2018-01-18

Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins capable of binding angiopoietin-2 (Ang-2) and methods of use thereof

#2178
20180015142
2018-01-18

THERAPEUTIC AND PROPHYLACTIC METHODS, USES AND COMPOSITIONS COMPRISING ANEXIN A5

#2179
20180015141
2018-01-18

Use of PRG4 as an anti-inflammatory agent

#2180
20180015124
2018-01-18

Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases

#2181
20180009872
2018-01-11

ANTAGONISTS OF ACTRIIB AND USES FOR INCREASING RED BLOOD CELL LEVELS

#2182
20180009863
2018-01-11

Composition and system for separating and detecting alpha-fetoprotein variant and use thereof

#2183
20180009862
2018-01-11

Modified ligand-gated ion channels and methods of use

#2184
20180009842
2018-01-11

Arginine-rich Peptide Mixture, their Application Thereof in Cervical Cancer Therapy, and a Process for Producing same

#2185
20180008679
2018-01-11

Compositions and methods of increasing longevity or treating cellular stress

#2186
20180008669
2018-01-11

ID4 PROTEIN RESTORES WILD TYPE P53 ACTIVITY

#2187
20180008556
2018-01-11

RETINOID REPLACEMENTS AND OPSIN AGONISTS AND METHODS FOR THE USE THEREOF

#2188
20180008458
2018-01-11

METHODS OF TREATING RETINAL DISEASES

#2189
20180002700
2018-01-04

Pharmaceutical composition for preventing or treating diabetic complications and screening method for preventive or therapeutic agent for diabetic complications

#2190
20180002661
2018-01-04

Compositions of active WNT protein

#2191
20180002413
2018-01-04

Inflammatory disease diagnosis and methods of treatment using down-regulators of lipopolysaccharide-responsive beige-like anchor

#2192
20180002389
2018-01-04

Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

#2193
20180000908
2018-01-04

Use of angiogenin or angiogenin agonists for treating diseases and disorders

#2194
20180000903
2018-01-04

Tablets comprising GLP-1 agonist and enteric coating

#2195
20180000901
2018-01-04

Use of peptide-based inhibitors of the stat3-IL10 pathway for treating bacterial infection and granulomatous disease

#2196
20180000896
2018-01-04

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#2197
20180000874
2018-01-04

Human disease mitigation with food formulation

#2198
20180000846
2018-01-04

Compositions and Methods for Treating Conditions That Affect Epidermis

#2199
20170368181
2017-12-28

Polymeric Nanoparticle

#2200
20170368158
2017-12-28

Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brain tumors

#2201
20170368142
2017-12-28

Methods of treating cognitive impairment

#2202
20170368139
2017-12-28

Co-activation of mTOR and STAT3 pathways to promote neuronal survival and regeneration

#2203
20170368138
2017-12-28

Method of treating cancer with a multiple integrin binding Fc fusion protein

#2204
20170368130
2017-12-28

STAT3 and ERK signal pathway inhibitor comprising mogrosides and analogs thereof

#2205
20170367982
2017-12-28

HIGH DENSITY LIPOPROTEIN FUNCTIONALIZED MAGNETIC NANOSTRUCTURES

#2206
20170362664
2017-12-21

Treatment of angiogenesis disorders

#2207
20170362173
2017-12-21

ANTI-ARRHYTHMICITY AGENTS

#2208
20170360886
2017-12-21

Methods for treating and preventing cardiomyopathy with a fusion protein of tafazzin and a cellular permeability peptide

#2209
20170360885
2017-12-21

Method of preventing or reducing the progression of prostate cancer

#2210
20170360838
2017-12-21

Factors and cells that provide for induction of bone, bone marrow, and cartilage

#2211
20170355778
2017-12-14

COMPOSITIONS AND METHODS OF TREATING TUMORS

#2212
20170355736
2017-12-14

MORTALIN PEPTIDES AND ANTIBODIES AND USES THEREOF FOR INHIBITING MORTALIN ACTIVITY AND TREATING A DISEASE ASSOCIATED WITH A PATHOLOGICAL CELL

#2213
20170354718
2017-12-14

Fibronectin based scaffold domain proteins that bind to myostatin

#2214
20170354711
2017-12-14

High density lipoprotein nanoparticles for inflammation

#2215
20170354688
2017-12-14

Therapeutic effects of NURR1 and FOXA2 in inflammatory neurologic disorders by M1-to-M2 polarization of glial cells

#2216
20170350891
2017-12-07

Pharmaceuticals and methods for treating hypoxia and screening methods therefor

#2217
20170348390
2017-12-07

Compositions and methods for treating mesothelioma post-surgery

#2218
20170348387
2017-12-07

AAV-MEDIATED GENE THERAPY FOR NPHP5 LCA-CILIOPATHY

#2219
20170343565
2017-11-30

Biomarkers for seizures

#2220
20170340715
2017-11-30

Materials and Methods Useful For Treating Glioblastoma

#2221
20170340712
2017-11-30

CAMKK1 as a novel regenerative therapeutic

#2222
20170340710
2017-11-30

Use of hepcidin as a regulator of iron homeostasis

#2223
20170340703
2017-11-30

Tear lipocalin muteins binding IL-4 R alpha

#2224
20170340702
2017-11-30

Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody

#2225
20170336395
2017-11-23

METHODS AND COMPOSITIONS FOR TREATING AMYLOID DEPOSITS

#2226
20170334960
2017-11-23

Methods and compositions for delivering interleukin-1 receptor antagonist

#2227
20170333571
2017-11-23

Targeted Delivery Platform for Delivery of Therapeutics

#2228
20170333528
2017-11-23

Methods and compositions for modulating myofibroblast activities

#2229
20170333523
2017-11-23

Whey Protein Micelles to Enhance Muscle Mass and Performance

#2230
20170333492
2017-11-23

Pharmaceutical composition for preventing or treating metabolic diseases, comprising bacteroides acidifaciens as active ingredient

#2231
20170333448
2017-11-23

Topically Active Steroids For Use in Radiation and Chemotherapeutics Injury

#2232
20170328899
2017-11-16

Autoantigen in idiopathic inflammatory myopathies

#2233
20170327556
2017-11-16

CARTILAGE-BINDING FUSION PROTEINS

#2234
20170327552
2017-11-16

Peptides and compositions for treatment of joint damage

#2235
20170326209
2017-11-16

BEVERAGE, AND METHOD OF PRODUCING THE SAME

#2236
20170326182
2017-11-16

Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition

#2237
20170322227
2017-11-09

Compositions and methods for treating eye infections and disease

#2238
20170322226
2017-11-09

COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE

#2239
20170320964
2017-11-09

Modulators of ACYL-COA lysocardiolipin acyltransferase 1 (ALCAT1) and uses thereof

#2240
20170320925
2017-11-09

Methods of increasing sarcolemmal utrophin

#2241
20170320913
2017-11-09

IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC

#2242
20170319654
2017-11-09

Method for treating microbial infection

#2243
20170319653
2017-11-09

METHOD OF TREATING MUCUS HYPERSECRETION

#2244
20170319652
2017-11-09

PREVENTION AND TREATMENT OF INFECTIONS

#2245
20170319622
2017-11-09

BIOACTIVE COMPOSITIONS DERIVABLE FROM PLATELET CONCENTRATES, AND METHODS FOR PREPARING AND USING SAME

#2246
20170319619
2017-11-09

Immunosuppressive blood cells and methods of producing the same

#2247
20170319525
2017-11-09

Treatment and diagnosis of melanoma

#2248
20170314027
2017-11-02

INCREASING ATOH1 LIFE TO DRIVE SENSORINEURAL HAIR CELL DIFFERENTIANTION

#2249
20170312393
2017-11-02

NOVEL WOUND-HEALING-ENHANCING DEVICES

#2250
20170312358
2017-11-02

Cytokines and neuroantigens for treatment of immune disorders

#2251
20170312336
2017-11-02

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#2252
20170312335
2017-11-02

TOPICAL USE OF PRG4 FOR TREATMENT OF ALLERGY AND SYMPTOMS OF INFLAMMATION

#2253
20170312334
2017-11-02

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY DISORDERS

#2254
20170312318
2017-11-02

Methods and compositions for in vivo induction of pancreatic beta cell formation

#2255
20170312268
2017-11-02

METHODS FOR TREATING A NEUROLOGICAL DISORDER IN A SUBJECT USING INHIBITORS OF HYPOXIA-INDUCIBLE FACTOR (HIF) PROYL HYDROXYLASE

#2256
20170305990
2017-10-26

Tmem100 peptides and variants thereof and their use in treating or preventing diseases or conditions

#2257
20170305981
2017-10-26

SYNTHETIC PEPTIDES

#2258
20170304465
2017-10-26

Adeno-associated viral vectors for treating myocilin (MYOC) glaucoma

#2259
20170304463
2017-10-26

Regenerating functional neurons for treatment of disease and injury in the nervous system

#2260
20170304410
2017-10-26

Treatment of cancer and inhibition of metastasis using hemoglobin beta subunit

#2261
20170304405
2017-10-26

Treatment of hormonal disorders of growth

#2262
20170304399
2017-10-26

NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER

#2263
20170304398
2017-10-26

POLYMER CONJUGATES OF BOX-A OF HMGB1 AND BOX-A VARIANTS OF HMGB1

#2264
20170298438
2017-10-19

DETECTION AND TREATMENT OF BREAST CANCER

#2265
20170298108
2017-10-19

Compositions comprising GRIM-19 therapeutics and methods of use

#2266
20170298107
2017-10-19

Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload

#2267
20170298105
2017-10-19

Methods for treatment of stroke or cerebrovascular accidents using an ETreceptor agonist

#2268
20170296624
2017-10-19

GLA DOMAINS AS TARGETING AGENTS

#2269
20170291932
2017-10-12

Osteogenic biomaterial

#2270
20170290886
2017-10-12

TREATMENT OF NEURODEVELOPMENTAL DISORDERS

#2271
20170290877
2017-10-12

Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases

#2272
20170290860
2017-10-12

Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy

#2273
20170283496
2017-10-05

OLIGONUCLEOTIDES FOR REDUCTION OF PD-L1 EXPRESSION

#2274
20170283477
2017-10-05

Animal model of longevity and related methods for increasing longevity and inhibiting tumorigenesis

#2275
20170281730
2017-10-05

Compositions and methods for the systemic treatment of arthritis

#2276
20170281726
2017-10-05

Methods and uses of slit for treating fibrosis

#2277
20170281724
2017-10-05

USE OF GELSOLIN TO DIAGNOSE AND TREAT INFLAMMATORY DISEASES

#2278
20170281723
2017-10-05

Peptidyl calcineurin inhibitors

#2279
20170281542
2017-10-05

Lipid formulations for delivery of messenger RNA

#2280
20170274077
2017-09-28

Methods for increasing red blood cell levels and treating ineffective erythropoiesis

#2281
20170274075
2017-09-28

Therapeutic and research application of PDCL3

#2282
20170274046
2017-09-28

COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF NEUROLOGICAL DISEASE

#2283
20170274045
2017-09-28

Sugar compositions for treating hemophilia A and/or Von Willebrand disease

#2284
20170274044
2017-09-28

Fusion protein comprising albumin and retinol-binding protein

#2285
20170274001
2017-09-28

Compositions and Methods for Increasing Red Blood Cells

#2286
20170268067
2017-09-21

Use of EI24 gene

#2287
20170266266
2017-09-21

Functions of 55 Newfound Proteins and Their Medicinal Application in the Treatment and Prevention of Disease

#2288
20170266261
2017-09-21

PROTEIN THERAPY FOR TREATMENT OF RETINAL DISEASES

#2289
20170266256
2017-09-21

Methods of promoting angiogenesis in tissue with fibromodulin

#2290
20170266255
2017-09-21

Pharmaceutical composition for treating bone diseases which comprises protein comprising Frizzled 1, Frizzled 2 or Frizzled 7 extracellular cysteine-rich domain

#2291
20170260256
2017-09-14

Modified colostrum protein and application thereof

#2292
20170260234
2017-09-14

ALZHEIMER'S DISEASE TREATMENT METHOD

#2293
20170258883
2017-09-14

Protease-engineered Cancer Cell Spheres as an Immunotherapy to Treat Cancer and non-Cancer Diseases

#2294
20170258873
2017-09-14

METHODS FOR DIAGNOSING, PROGNOSING AND TREATING MUSCULAR DYSTROPHY

#2295
20170258872
2017-09-14

DPEP-1 binding compositions and methods of use

#2296
20170258110
2017-09-14

METHOD OF USE OF ACTIVATED FUNCTIONAL PROTEINS TO IMPROVE ANIMAL HEALTH

#2297
20170253641
2017-09-07

Medicament for Atrophy Treatment or Increasing Cell Growth

#2298
20170253639
2017-09-07

Nutritive fragments, proteins and methods

#2299
20170252402
2017-09-07

METHODS FOR TREATING TISSUE DAMAGE ASSOCIATED WITH ISCHEMIA WITH APOLIPOPROTEIN D

#2300
20170252401
2017-09-07

Systems and methods for attracting and trapping brain cancer cells

#2301
20170247423
2017-08-31

STAPLED INTRACELLULAR-TARGETING ANTIMICROBIAL PEPTIDES TO TREAT INFECTION

#2302
20170247417
2017-08-31

T-cell redirecting bispecific antibodies for treatment of disease

#2303
20170246322
2017-08-31

Guided injections for AAV gene transfer to muscle

#2304
20170246269
2017-08-31

METHODS OF TREATING OR PREVENTING PERIODONTITIS AND DISEASES ASSOCIATED WITH PERIODONTITIS

#2305
20170246248
2017-08-31

Oligopeptidic compounds and uses thereof

#2306
20170246247
2017-08-31

Use Of SCO-Spondin Peptides For Inhibiting Or Preventing Neuronal Apoptosis Mediated By Cell Death Receptor Ligands

#2307
20170246246
2017-08-31

Compositions and methods for inhibiting intercellular interactions

#2308
20170240966
2017-08-24

PREDICTING AMD WITH SNPS WITHIN OR NEAR C2, FACTOR B, PLEKHA1, HTRA1, PRELP, OR LOC387715

#2309
20170240885
2017-08-24

Selective recovery

#2310
20170240606
2017-08-24

Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

#2311
20170240605
2017-08-24

Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

#2312
20170239373
2017-08-24

Generating GABAergic neurons in brains

#2313
20170239331
2017-08-24

FORMULATIONS FOR HISTATIN PROTECTIVES AND THERAPEUTICS

#2314
20170239330
2017-08-24

FORMULATIONS FOR HISTATIN THERAPEUTICS

#2315
20170239329
2017-08-24

THERAPEUTIC COMPOSITION COMPRISING ANNEXIN V

#2316
20170239248
2017-08-24

Pathogenic control of apoptosis

#2317
20170233444
2017-08-17

RTEF-1 VARIANTS AND USES THEREOF

#2318
20170233443
2017-08-17

CYCLIC POLYPEPTIDES FOR THE TREATMENT OF HEART FAILURE

#2319
20170233442
2017-08-17

Peptidylic inhibitors of nucleolin (NCL) targeting CAG-repeat RNA toxicity and methods for reducing polyQ-mediated toxicity in polyQ diseases

#2320
20170233434
2017-08-17

Method for separating proteins from animal or human plasma, or plants, using a pH gradient method

#2321
20170232081
2017-08-17

Methods for treatment of and prophylaxis against inflammatory disorders

#2322
20170232076
2017-08-17

Mannose-6-phosphate bearing peptides fused to lysosomal enzymes

#2323
20170232064
2017-08-17

FORMULATIONS FOR HISTATIN THERAPEUTICS

#2324
20170232063
2017-08-17

USES OF CASEIN COMPOSITIONS

#2325
20170232062
2017-08-17

POLYPEPTIDES AND USES THEREOF AS A DRUG FOR TREATMENT OF MULTIPLE SCLEROSIS, RHEUMATOID ARTHRITIS AND OTHER AUTOIMMUNE DISORDERS

#2326
20170226168
2017-08-10

Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof

#2327
20170224843
2017-08-10

GENOME EDITING FOR THE TREATMENT OF HUNTINGTON'S DISEASE

#2328
20170224792
2017-08-10

Methods for diagnosing and treating Alzheimer's disease

#2329
20170224771
2017-08-10

HISTATINS AS THERAPEUTIC AGENTS FOR OCULAR SURFACE DISEASE

#2330
20170224770
2017-08-10

Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation

#2331
20170224769
2017-08-10

Pharmaceutical composition for suppressing cell transplant rejection

#2332
20170224737
2017-08-10

Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling

#2333
20170224620
2017-08-10

Therapeutic nanoparticles having EGFR ligands and methods of making and using same

#2334
20170219580
2017-08-03

Methods and kits for monitoring membranous nephropathy

#2335
20170218037
2017-08-03

Compositions and methods for treatment of muscular dystrophy

#2336
20170216458
2017-08-03

INTRATHECAL DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS 9

#2337
20170215442
2017-08-03

Process for producing a composition for increasing muscle mass

#2338
20170209598
2017-07-27

Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides

#2339
20170209538
2017-07-27

PAX6 minipromoters

#2340
20170209537
2017-07-27

ApoE mimetic peptides and higher potency to clear plasma cholesterol

#2341
20170209536
2017-07-27

SOCS1-derived peptide for use in chronic complications of diabetes

#2342
20170209371
2017-07-27

Phosphoserine containing compositions for immune tolerance induction

#2343
20170204160
2017-07-20

Use of HDL-related molecules to treat and prevent proinflammatory conditions

#2344
20170204148
2017-07-20

PEPTIDE-BASED STAT INHIBITOR

#2345
20170202914
2017-07-20

Use of annexin v as a method to block tumor induced immunosuppression of the innate immune response

#2346
20170202912
2017-07-20

OPTOGENETIC CONTROL OF INPUTS TO THE VENTRAL TEGMENTAL AREA

#2347
20170202910
2017-07-20

DIFFERENTIATION MARKER AND DIFFERENTIATION CONTROL OF EYE CELL

#2348
20170202866
2017-07-20

Method of promoting wound healing

#2349
20170202784
2017-07-20

CONFIGURABLE CLATHRIN LIGHT CHAIN COMPOSITION

#2350
20170198054
2017-07-13

METHODS FOR TREATING CANCER WITH ANTI BIP OR ANTI MICA ANTIBODIES

#2351
20170197011
2017-07-13

METHODS FOR REPAIRING CARTILAGE DAMAGE

#2352
20170196935
2017-07-13

Reconstituted high density lipoprotein formulation and production method thereof

#2353
20170196933
2017-07-13

Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof

#2354
20170191039
2017-07-06

Recombinant AAVS having useful transcytosis properties

#2355
20170190754
2017-07-06

Cell-permeable (iCP)-SOCS3 recombinant protein and uses thereof

#2356
20170189483
2017-07-06

Diagnostic and therapeutic uses of gelsolin in renal failure

#2357
20170189482
2017-07-06

Mutant NGAL proteins and uses thereof

#2358
20170189481
2017-07-06

Use of peptides that block metadherin-SND1 interaction as treatment for cancer

#2359
20170189480
2017-07-06

Medical agents and uses thereof

#2360
20170189450
2017-07-06

Gene correction of SCID-related genes in hematopoietic stem and progenitor cells

#2361
20170182207
2017-06-29

WOUND-HEALING-ENHANCING DEVICES

#2362
20170182121
2017-06-29

Charged lipoprotein complexes and their uses

#2363
20170182120
2017-06-29

Method of preventing polycystic kidney disease and PKD animal model with exogenous neutrophil gelatinase-associated lipocalin

#2364
20170182119
2017-06-29

Compositions and methods for modulating NCOA4-mediated autophagic targeting of ferritin

#2365
20170182109
2017-06-29

APPETITE-SUPPRESSING AGENT

#2366
20170176457
2017-06-22

Compositions and methods for treating eye infections and disease

#2367
20170174747
2017-06-22

Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content

#2368
20170173183
2017-06-22

Gene therapy for retinitis pigmentosa

#2369
20170173112
2017-06-22

NOVEL BINDING PROTEINS FOR PCSK9

#2370
20170173111
2017-06-22

Semaphorin 3C variants, compositions comprising said variants and methods of use thereof in treating eye diseases

#2371
20170173079
2017-06-22

Method of ex vivo enhancement of immune cell activity for cancer immunotherapy with a small molecule ablative compound

#2372
20170166926
2017-06-15

Targeting peptides for directing adeno-associated viruses (AAVs)

#2373
20170166925
2017-06-15

Recombinant AAV vectors useful for reducing immunity against transgene products

#2374
20170165324
2017-06-15

CLATHRIN REPLACEMENT THERAPEUTICS

#2375
20170165323
2017-06-15

Pharmaceutical compositions for treating or preventing bone conditions

#2376
20170165322
2017-06-15

PEPTIDE AND SMALL MOLECULE AGONISTS OF EPHA AND THEIR USES IN DISEASE

#2377
20170165200
2017-06-15

COMPOSITION OF LIPID-BASED NANOPARTICLES FOR SMALL MOLECULES AND MACROMOLECULES

#2378
20170159021
2017-06-08

Method and composition for inducing human pluripotent stem cells

#2379
20170158751
2017-06-08

MODULATING DISEASE THROUGH GENETIC ENGINEERING OF PLANTS

#2380
20170158744
2017-06-08

Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders

#2381
20170157212
2017-06-08

CDK MODULATORS AND METHODS FOR THE TREATMENT OF CANCER

#2382
20170157211
2017-06-08

Trefoil family factor proteins and uses thereof

#2383
20170157210
2017-06-08

CAPCNA peptide therapeutics for cancer

#2384
20170157209
2017-06-08

Prescription of intravenous medication for blocking heroin or morphine intoxication path and using thereof

#2385
20170157149
2017-06-08

Compositions and methods for disease treatment using nanoparticle delivered compounds

#2386
20170156389
2017-06-08

Fermented infant formula with non digestible oligosaccharides

#2387
20170153224
2017-06-01

Flattop (FLTP) is a novel biomarker for beta cell maturation

#2388
20170152564
2017-06-01

MECP2E1 GENE

#2389
20170152296
2017-06-01

COMPOSITIONS FOR THE TREATMENT OF WOUNDS

#2390
20170151349
2017-06-01

Particles comprising protamine and RNA in combination with endosome destabilizing agents

#2391
20170151345
2017-06-01

Methods for treating cancer with EGFR nanobodies linked to DR5 binding moieties

#2392
20170151309
2017-06-01

Peptide and uses therefor

#2393
20170151287
2017-06-01

METHODS AND COMPOSITIONS OF CHONDRISOMES

#2394
20170145382
2017-05-25

Method for stem cell differentiation in vivo by delivery of morphogenes with mesoporous silica and corresponding pharmaceutical active ingredients

#2395
20170143685
2017-05-25

Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit

#2396
20170136098
2017-05-18

Methods for treating neurological conditions and compositions and materials therefor

#2397
20170135915
2017-05-18

Use of exosomes to promote or enhance hair growth

#2398
20170129934
2017-05-11

Natriuretic polypeptides

#2399
20170128570
2017-05-11

Annexin II compositions

#2400
20170128534
2017-05-11

Treating rotator cuff conditions